Markets & Finance

Estimates Raised for IDEC Pharmaceuticals


Company: IDEC Pharmaceuticals (IDPH)

Fiscal year end: Dec-01

Prior: 1.15

New: 1.37

Rationale: Higher sales & interest income

Company: IMC Global (IGL)

Fiscal year end: Dec-01

Prior: 1.40

New: 0.80

Rationale: Shutdown of phosphate capacity

Company: Lucent Technologies (LU)

Fiscal year end: Sep-01

Prior: 0.40

New: 0.19

Rationale: Preannounced weak Q1

Company: Lyondell Chemical (LYO)

Fiscal year end: Dec-01

Prior: 1.00

New: 0.75

Rationale: Higher feedstock costs

Company: UCAR International (UCR)

Fiscal year end: Dec-01

Prior: 1.35

New: 1.05

Rationale: Slowing global steel production

Company: WorldCom (WCOM)

Fiscal year end: Dec-01

Prior: 2.00

New: 1.25

Rationale: Pricing pressures


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Sponsored Financial Commentaries

Sponsored Links

Buy a link now!

 
blog comments powered by Disqus